BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29022503)

  • 1. The Renal Outer Medullary Potassium Channel (ROMK): An Intriguing Pharmacological Target for an Innovative Class of Diuretic Drugs.
    Calderone V; Martelli A; Piragine E; Citi V; Testai L; Breschi MC
    Curr Med Chem; 2018; 25(23):2627-2636. PubMed ID: 29022503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/Natriuretic.
    Jiang J; Ding FX; Zhou X; Bateman TJ; Dong S; Gu X; Keh deJesus R; Pio B; Tang H; Chobanian HR; Levorse D; Hu M; Thomas-Fowlkes B; Margulis M; Koehler M; Weinglass A; Gibson J; Houle K; Yudkovitz J; Hampton C; Pai LY; Samuel K; Cutarelli T; Sullivan K; Parmee ER; Davies I; Pasternak A
    J Med Chem; 2021 Jun; 64(11):7691-7701. PubMed ID: 34038119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ROMK blocks macula densa tubuloglomerular feedback yet causes renal vasoconstriction in anesthetized rats.
    Araujo M; Welch WJ; Zhou X; Sullivan K; Walsh S; Pasternak A; Wilcox CS
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1120-F1127. PubMed ID: 28228405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics.
    Aretz CD; Vadukoot AK; Hopkins CR
    J Med Chem; 2019 Oct; 62(19):8682-8694. PubMed ID: 31034224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the renal outer medullary potassium channel: a patent review.
    Martelli A; Testai L; Breschi MC; Calderone V
    Expert Opin Ther Pat; 2015; 25(9):1035-51. PubMed ID: 26004420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.
    Hampton C; Zhou X; Priest BT; Pai LY; Felix JP; Thomas-Fowlkes B; Liu J; Kohler M; Xiao J; Corona A; Price O; Gill C; Shah K; Rasa C; Tong V; Owens K; Ormes J; Tang H; Roy S; Sullivan KA; Metzger JM; Alonso-Galicia M; Kaczorowski GJ; Pasternak A; Garcia ML
    J Pharmacol Exp Ther; 2016 Oct; 359(1):194-206. PubMed ID: 27432892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.
    Richter JM; Gunaga P; Yadav N; Bora RO; Bhide R; Rajugowda N; Govindrajulu K; Godesi S; Akuthota N; Rao P; Sivaraman A; Panda M; Kaspady M; Gupta A; Mathur A; Levesque PC; Gulia J; Dokania M; Ramarao M; Kole P; Chacko S; Lentz KA; Sivaprasad Lvj S; Thatipamula RP; Sridhar S; Kamble S; Govindrajan A; Soleman SI; Gordon DA; Wexler RR; Priestley ES
    J Med Chem; 2024 Jun; 67(11):9731-9744. PubMed ID: 38807539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the inward-rectifier potassium channel ROMK in cardiovascular disease.
    Garcia ML; Kaczorowski GJ
    Curr Opin Pharmacol; 2014 Apr; 15():1-6. PubMed ID: 24721647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of targeting the K
    Priest BT; Pasternak A
    Future Med Chem; 2017 Oct; 9(16):1963-1977. PubMed ID: 29076349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.
    Tang H; de Jesus RK; Walsh SP; Zhu Y; Yan Y; Priest BT; Swensen AM; Alonso-Galicia M; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Zhou X; Pai LY; Hampton C; Hernandez M; Owens K; Roy S; Kaczorowski GJ; Yang L; Garcia ML; Pasternak A
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5829-32. PubMed ID: 24075732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.
    Garcia ML; Priest BT; Alonso-Galicia M; Zhou X; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Liu J; Swensen A; Pai LY; Xiao J; Hernandez M; Hoagland K; Owens K; Tang H; de Jesus RK; Roy S; Kaczorowski GJ; Pasternak A
    J Pharmacol Exp Ther; 2014 Jan; 348(1):153-64. PubMed ID: 24142912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROMK inhibitor actions in the nephron probed with diuretics.
    Kharade SV; Flores D; Lindsley CW; Satlin LM; Denton JS
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F732-F737. PubMed ID: 26661652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
    Bhave G; Chauder BA; Liu W; Dawson ES; Kadakia R; Nguyen TT; Lewis LM; Meiler J; Weaver CD; Satlin LM; Lindsley CW; Denton JS
    Mol Pharmacol; 2011 Jan; 79(1):42-50. PubMed ID: 20926757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.
    Lewis LM; Bhave G; Chauder BA; Banerjee S; Lornsen KA; Redha R; Fallen K; Lindsley CW; Weaver CD; Denton JS
    Mol Pharmacol; 2009 Nov; 76(5):1094-103. PubMed ID: 19706730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
    Welling PA; Ho K
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F849-63. PubMed ID: 19458126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics.
    Chobanian HR; Guo Y; Pio B; Tang H; Teumelsan N; Clements M; Frie J; Ferguson R; Guo Z; Thomas-Fowlkes BS; Felix JP; Liu J; Kohler M; Priest B; Hampton C; Pai LY; Corona A; Metzger J; Tong V; Joshi EM; Xu L; Owens K; Maloney K; Sullivan K; Pasternak A
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1109-1114. PubMed ID: 28111141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered renal expression of Na(+) transporters and ROMK in protein-deprived rats.
    Ruete MC; Carrizo LC; Bocanegra MV; Vallés PG
    Nephron Physiol; 2009; 111(3):p17-29. PubMed ID: 19202345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium excretion through ROMK potassium channel expressed in gill mitochondrion-rich cells of Mozambique tilapia.
    Furukawa F; Watanabe S; Kimura S; Kaneko T
    Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(5):R568-76. PubMed ID: 22204952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Inhibition of Renal Outer Medullary Potassium Channel Not Only Prevented but Also Reversed Development of Hypertension and End-Organ Damage in Dahl Salt-Sensitive Rats.
    Zhou X; Forrest MJ; Sharif-Rodriguez W; Forrest G; Szeto D; Urosevic-Price O; Zhu Y; Stevenson AS; Zhou Y; Stribling S; Dajee M; Walsh SP; Pasternak A; Sullivan KA
    Hypertension; 2017 Feb; 69(2):332-338. PubMed ID: 27920129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.